Document complet  |  Dérouler chapitre  |  Etendre sommaire  |  Version HTML imprimable
The Quality of Antimalarials - A Study in Selected African Countries - EDM Research Series No. 030
(2003; 67 pages) Voir le document au format PDF
Table des matières
Afficher le documentAuthors
Afficher le documentCountry Research Team Leaders
Afficher le documentLaboratory Support
Afficher le documentAcknowledgements
Afficher le documentAcronyms
Afficher le documentExecutive summary
Afficher le document1. Background
Ouvrir ce répertoire et afficher son contenu2. Methodology
Afficher le document3. Results
Ouvrir ce répertoire et afficher son contenu4. Discussion
Ouvrir ce répertoire et afficher son contenu5. Conclusions and recommendations
Afficher le documentReferences
Ouvrir ce répertoire et afficher son contenuTables
Ouvrir ce répertoire et afficher son contenuAnnexes
Afficher le documentOther documents in the EDM Research Series
Afficher le documentEDM Research Series No. 30
 

EDM Research Series No. 30

The Department of Essential Drugs and Medicines Policy (EDM) of the World Health Organization works to ensure that all people ⊥ wherever they may be ⊥ are able to obtain the drugs they need at a price that they and their country can afford, that these medicines are safe

Ensuring access to and rational use of medicines for all people is a difficult goal in itself, especially given today’s rapidly changing macroeconomic and national environments. Countries are experiencing the impacts of structural adjustment policies, globalization of world markets and new disease patterns. Widespread health system reforms with shifting priorities, and the changing relationship between the public and private sectors, further complicate this picture. Additionally, many governments lack crucial information to guide their national medicines policies in response to these challenges.

But operational research is making a vital contribution to identifying global and national drug sector problems and priority areas for intervention. At global level, the systematic development and analysis of internationally comparable data on pharmaceutical systems is enabling countries to learn from each other's experience and to strengthen their national drug policies. At the same time, national research is helping countries to analyse and overcome the constraints they face in developing and implementing these policies.

This document is just one in a series of research guidelines and studies that are helping to reduce the burden of disease and provide access to responsive health care for all.

Department of Essential Drugs and Medicines Policy, World Health Organization, 1211 Geneva 27, Switzerland

vers la section précédente
 
 
Le Portail d'information - Médicaments essentiels et produits de santé a été conçu et est maintenu par l'ONG Human Info. Dernière mise à jour: le 29 octobre 2018